HSBC Holdings
TSVT

HSBC Holdings’s 2seventy bio TSVT Stock Holding History

HSBC Holdings’s Portfolio TSVT Stock Details TSVT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-62,574
Closed -$309K – 3248
2025
Q1 		$309K Sell
62,574
-6,071
-9% -$19.3K ﹤0.01% 2356
2024
Q4 		$198K Sell
68,645
-1,265
-2% -$5.19K ﹤0.01% 2724
2024
Q3 		$338K Buy
69,910
+1,321
+2% +$5.96K ﹤0.01% 2254
2024
Q2 		$259K Buy
68,589
+393
+0.6% +$1.77K ﹤0.01% 2389
2024
Q1 		$365K Sell
68,196
-5,514
-7% -$25.9K ﹤0.01% 2291
2023
Q4 		$318K Sell
73,710
-14,118
-16% -$43.4K ﹤0.01% 2256
2023
Q3 		$339K Buy
+87,828
New +$576K ﹤0.01% 2160

Other funds holding TSVT

N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

HSBC Holdings's TSVT Position: Q2 2025 in Review

HSBC Holdings sold out of 2seventy bio (TSVT) in Q2 2025, closing a stake of 62,574 shares — an estimated $309K sold.

HSBC Holdings first reported a position in TSVT in Q3 2023 and held it in 7 quarters. The position peaked at $365K in Q1 2024. 2 funds tracked by Wall St. Rank hold TSVT as of Q2 2025.

  • HSBC Holdings reported no remaining 2seventy bio position as of Q2 2025 after selling out during the quarter.
  • HSBC Holdings sold 62,574 2seventy bio shares in Q2 2025, an estimated $309K.
  • HSBC Holdings first reported a position in 2seventy bio in Q3 2023 and held it in 7 quarters.
  • HSBC Holdings's 2seventy bio position peaked at $365K in Q1 2024.
  • 2 funds tracked by Wall St. Rank held 2seventy bio as of Q2 2025.

Based on HSBC Holdings's 13F filing for Q2 2025, filed 13 Aug 2025.